IRVINE, Calif. — August 29, 2025 — Leads & Copy — Eledon Pharmaceuticals, Inc. (Nasdaq: ELDN) announced that CEO David-Alexandre C. Gros, M.D., will participate in a fireside chat at the Cantor Global Healthcare Conference on Friday, September 5, 2025, at 9:10 a.m. ET (6:10 a.m. PT).
Those wishing to register in advance for the fireside chat webcast can sign up here. A webcast replay will be accessible following the live session on the Company’s website under Events.
Eledon Pharmaceuticals is a clinical stage biotechnology company developing immune-modulating therapies for life-threatening conditions. The Company’s lead investigational product is tegoprubart, an anti-CD40L antibody. Eledon is headquartered in Irvine, California.
Investor Contact: Stephen Jasper, Gilmartin Group, (858) 525 2047, stephen@gilmartinir.com; Media Contact: Jenna Urban, CG Life, (212) 253 8881, jurban@cglife.com
Source: Eledon Pharmaceuticals
